Curaleaf Holdings, Inc. (CURLF)

OTCMKTS: CURLF · Delayed Price · USD
5.34
-0.16 (-2.91%)
Mar 28, 2024, 3:59 PM EDT - Market closed

Company Description

Curaleaf Holdings, Inc. operates a cannabis operator in the United States.

It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels.

The company is headquartered in New York, New York.

Curaleaf Holdings, Inc.
Curaleaf Holdings logo
Country NY
Founded 2010
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 5,650
CEO Matthew S. Darin

Contact Details

Address:
420 Lexington Avenue
New York, New York 10170
United States
Phone 781-451-0117
Website curaleaf.com

Stock Details

Ticker Symbol CURLF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001756770
CUSIP Number 23126M102
ISIN Number CA23126M1023
SIC Code 2833

Key Executives

Name Position
Boris Alexis Jordan Executive Chairman
Matthew S. Darin Chief Executive Officer
Joseph F. Lusardi Executive Vice-Chairman
Edward Kremer Chief Financial Officer
Camilo Russi Lyon Chief Investment Officer
Jakob Feinstein Manager of Investor Relations
Peter Laurence Clateman J.D. Chief Legal Officer
James S. Shorris Chief Compliance Officer
Tracy Brady Senior Vice President of Corporate Communications
Kate Lynch Executive Vice President of Marketing

Latest SEC Filings

Date Type Title
Mar 19, 2024 6-K Report of foreign issuer
Mar 7, 2024 40-F Filing
Feb 13, 2024 6-K Report of foreign issuer
Feb 13, 2024 6-K Report of foreign issuer
Jan 26, 2024 6-K Report of foreign issuer
Dec 19, 2023 6-K Report of foreign issuer
Dec 8, 2023 6-K Report of foreign issuer
Nov 13, 2023 6-K Report of foreign issuer
Nov 9, 2023 6-K Report of foreign issuer
Oct 16, 2023 6-K Report of foreign issuer